Organizers:
Terri Grodzicker, David Stewart & Bruce Stillman
Cold Spring Harbor Laboratory

Past Program

We are pleased to host the 73rd Cold Spring Harbor Symposium which will address Control & Regulation of Stem Cells. The Symposium will begin at 7:30 pm on Wednesday, May 28, 2008 and end on the evening of Monday June 2 with normal departure on the following morning.

The Symposium will include 12/13 oral sessions and 2/3 poster sessions covering the latest findings in stem cell biology. Most of the talks will be given by invited speakers but we may select a few talks from openly submitted abstracts. Social events throughout the Symposium provide ample opportunity for informal interactions and will include a wine-and-cheese party, a beach picnic, cocktails and banquet, and departure brunch.

Topics:
• Signaling in stem cells
• Epigenetics & reprogramming
• miRNAs and stem cell control
• ES, EG and germ cells
• Cancer stem cells
• Hematopoietic stem cells
• Neural stem cells
• Intestinal, pancreatic, endodermal stem cells
• Stem cells of skin
• Breast stem cells
• Lung and heart stem cells
• Human stem cells
• Invertebrate systems
• Plant stem cells
• Nuclear transfer
• Aging & regeneration
• Clinical approaches

Speakers:
Jerry Adams, Walter & Eliza Institute of Medical Research, Australia
Arturo Alvarez-Buylla, University of California, San Francisco
Andrea Brand, University of Cambridge, UK
Margaret Buckingham, Pasteur Institute, France
Kenneth Chien, Massachusetts General Hospital
Michael Clarke, Stanford University
Hans Clevers, Utrecht University , The Netherlands
George Daley, Children's Hospital Boston
Ronald DePinho, Dana Farber Cancer Institute
Elaine Fuchs, The Rockefeller University/HHMI
Margaret Fuller, Stanford University School of Medicine
Nicholas Gaiano, Johns Hopkins School of Medicine
John Gearhart, Johns Hopkins School of Medicine
D. Gary Gilliland, Brigham & Women's Hospital/HHMI
Ueli Grossniklaus, University of Zurich, Switzerland
Gregory Hannon, Cold Spring Harbor Laboratory
Kristian Helin, Biotech Research & Innovation Centre, Denmark
Konrad Hochedlinger, Harvard University
Brigid Hogan, Duke University Medical Center
Juan Carlos Izpisua Belmonte, The Salk Insitute
Rudolf Jaenisch, Whitehead Institute for Biomedical Research
Gordon Keller, McEwen Center for Regenerative Medicine, Canada
Carla Kim, Children's Hospital, Boston
Judith Kimble, University of Wisconsin/HHMI
Ruth Lehmann, Skirball Institute, NYU School of Medicine
Ihor Lemischka, Mt. Sinai School of Medicine
Haifan Lin, Yale University School of Medicine
Sadhan Majumder, UT MD Anderson Cancer Center
Mirjana Maletic-Savatic, Stony Brook U. Medical Center
Robert Martienssen, Cold Spring Harbor Laboratory
Ronald McKay, National Insitutes of Health
Douglas Melton, Harvard University, HHMI
Sean Morrison, University of Michigan
Phillip Newmark, University of Illinois at Urbana-Champaign
Huck-Hui Ng, Genome Institute of Singapore
Shin-Ichi Nishikawa, RIKEN Center of Developmental Biology, Japan
Roel Nusse, Stanford University/HHMI
Stuart Orkin, Children's Hospital/HHMI
Luis Parada, UT Southwestern Medical Center
Thomas Rando, Stanford University School of Medicine
Steven Reiner, University of Pennsylvania
Jeremy Rich, Duke University Medical Center
Rodney Rothstein, Columbia University Medical Center
Michael Rudnicki, Ottawa Health Research Institute, Canada
Alejandro Sanchez Alvarado, University of Utah
Guy Sauvageau, IRIC, University of Montreal, Canada
Ben Scheres, Utrecht University, The Netherlands
Michael Shen, Columbia University Medical Center
Charles Sherr, St. Jude's Children's Hospital/HHMI
Takashi Shinohara, Kyoto University, Japan
Davor Solter, Max-Planck-Institute, Germany
Allan Spradling, Carnegie Institute of Washington
Lorenz Studer, Memorial Sloan Kettering Cancer Center
Azim Surani, Wellcome Trust/CRC Institute, UK
Elly Tanaka, Max Planck Institute of Molecular Cell Biology & Genetics, Germany
Marja Timmermans, Cold Spring Harbor Laboratory
Robert Tjian, University of California, Berkeley
Jane Visvader, Walter & Eliza Hall Institute, Australia
Amy Wagers, Joslin Diabetes Center
Fiona Watt, CR UK Cambridge Research Institute, UK
Irving Weissman, Stanford University School of Medicine
Max Wicha, University of Michigan
Owen Witte, University of California, Los Angeles/HHMI
Ting Xie, Stowers Institute for Medical Research
Shosei Yoshida, Kyoto University School of Medicine, Japan
Richard Young, Whitehead Institute/MIT
Kenneth Zaret, Fox Chase Cancer Center
Leonard Zon, Children's Hospital
Thomas Zwaka, Baylor College of Medicine

Session Chair:
Alan Trounson,California Institute for Regenerative Medicine

We are accepting abstracts for consideration as poster presentations. Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Status of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

Some special funds are available to help junior scientists wishing to actively present their work at the Symposium (US minorities are particularly encouraged to apply).

We look forward to seeing you at Cold Spring Harbor in May/June.

	The 73rd Symposium is generously supported by the Champalimaud Foundation, a Lisbon-based international organization with an ongoing interest in basic and clinical aspects of stem cells.
The Symposium is supported in part by funds provided by CSHL's Corporate Sponsor Program and the National Institutes of Health.
We have funds to provide partial scholarships for individuals who are US citizens/permanent residents from minority groups under-represented in the life sciences. Please provide justification in writing to meetings@cshl.edu and state your financial needs. Preference will be given to those applying who submit abstracts.

 

---

Regular packages are all inclusive and cover registration, food, housing, parking, wine-and-cheese party, lobster banquet, etc. No Housing packages include all costs except housing. Full payment is due 4 weeks prior to the meeting.